NEW YORK (GenomeWeb News) – Enzo Biochem today said that the Board of Patent Appeals and Interferences of the US Patent and Trademark Office has denied Siemens Healthcare Diagnostics' request for a rehearing in a patent interference case with Enzo Life Sciences.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.